ATE261301T1 - Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel - Google Patents
Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittelInfo
- Publication number
- ATE261301T1 ATE261301T1 AT95936694T AT95936694T ATE261301T1 AT E261301 T1 ATE261301 T1 AT E261301T1 AT 95936694 T AT95936694 T AT 95936694T AT 95936694 T AT95936694 T AT 95936694T AT E261301 T1 ATE261301 T1 AT E261301T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- steroidal anti
- date
- sec
- inflammatory drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA949055 | 1994-11-15 | ||
| PCT/GB1995/002679 WO1996014839A1 (en) | 1994-11-15 | 1995-11-14 | Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE261301T1 true ATE261301T1 (de) | 2004-03-15 |
Family
ID=25584578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95936694T ATE261301T1 (de) | 1994-11-15 | 1995-11-14 | Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5854226A (de) |
| EP (1) | EP0792147B1 (de) |
| JP (1) | JPH10508835A (de) |
| CN (1) | CN1171738A (de) |
| AT (1) | ATE261301T1 (de) |
| AU (1) | AU694577B2 (de) |
| DE (1) | DE69532678D1 (de) |
| WO (1) | WO1996014839A1 (de) |
| ZA (1) | ZA959469B (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283029B1 (it) * | 1996-05-17 | 1998-04-03 | Resa Farma | Composizioni farmaceutiche a base di diclofenac |
| AU5774796A (en) * | 1995-06-13 | 1997-01-09 | Dyer, Alison Margaret | Pharmaceutical compositions containing lornoxicam and cyclod extrin |
| US7687542B2 (en) | 1996-05-17 | 2010-03-30 | Kowa Pharmaeuticals America, Inc. | Rapidly bioavailable tablet and capsule formulations of diclofenac |
| US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
| FR2768339A1 (fr) * | 1997-09-18 | 1999-03-19 | Neufville Axel De | Utilisation d'un oxicam en tant qu'anti-migraineux |
| EA004032B1 (ru) * | 1998-09-10 | 2003-12-25 | Нюкомед Данмарк А/С | Фармацевтические композиции лекарственных веществ с быстрым высвобождением |
| US8231899B2 (en) | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
| DE19912436A1 (de) * | 1999-03-19 | 2000-09-21 | Merckle Gmbh | Ibuprofen-Lösung |
| ES2171110B1 (es) * | 2000-03-03 | 2003-06-16 | Aplicaciones Farmacodinamicas | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| US20050227911A1 (en) * | 2001-09-28 | 2005-10-13 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| US20050233003A1 (en) * | 2001-09-28 | 2005-10-20 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid |
| US6878693B2 (en) * | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
| US7700851B2 (en) * | 2001-11-13 | 2010-04-20 | U.S. Smokeless Tobacco Company | Tobacco nicotine demethylase genomic clone and uses thereof |
| ITMI20012749A1 (it) * | 2001-12-21 | 2003-06-21 | Chiesi Farma Spa | Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut |
| AU2003270727A1 (en) * | 2002-09-17 | 2004-04-08 | Luna Innovations, Inc. | Remote temperature sensing of small volume and related apparatus thereof |
| US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
| BRPI0508063A (pt) * | 2004-06-29 | 2007-07-17 | Nycomed Danmark Aps | processo para a manufatura de uma composição farmacêutica, nsaid, e, composição farmacêutica |
| BRPI0512756A (pt) | 2004-07-07 | 2008-04-08 | Aft Pharmaceuticals Ltd | composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas |
| US20060088590A1 (en) * | 2004-10-22 | 2006-04-27 | Banner Pharmacaps, Inc. | Non-blooming gelatin and non-gelatin formulations |
| CN101291683B (zh) * | 2004-11-24 | 2011-08-17 | 纽普罗研究有限公司 | 治疗疾病的方法和组合物 |
| JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
| EP3263117A1 (de) | 2005-11-28 | 2018-01-03 | Imaginot Pty Ltd. | Abgabesystem für eine orale therapeutische verbindung |
| US7700125B2 (en) | 2006-02-07 | 2010-04-20 | Kowa Pharmaceuticals America, Inc. | Moisture resistant container systems for rapidly bioavailable dosage forms |
| US7939561B2 (en) | 2006-02-07 | 2011-05-10 | Apr Applied Pharma Research S.A. | Blister packaging for acute pain regimens |
| EP2522343A1 (de) * | 2006-03-28 | 2012-11-14 | Javelin Pharmaceuticals, Inc. | Formulierungen aus niedrigdosiertem Diclofenac und Beta-Cyclodextrin |
| MX2008012496A (es) * | 2006-03-28 | 2009-01-07 | Javelin Pharmaceuticals Inc | Formulaciones de farmacos anti-inflamatorios no esteroidales de baja dosis y beta-ciclodextrina. |
| CA2647835A1 (en) * | 2006-03-28 | 2007-10-04 | Neopro Labs, Llc | Methods and compositions for treating conditions |
| CN100560058C (zh) * | 2006-05-23 | 2009-11-18 | 姚俊华 | 一种口服、快速起效的镇痛药物 |
| US7985542B2 (en) | 2006-09-07 | 2011-07-26 | Institut Pasteur | Genomic morse code |
| EP1974751A1 (de) * | 2007-03-26 | 2008-10-01 | The Jordanian Pharmaceutical Manufacturing Co. | Formulierungen für nichtsteroidale entzündungshemmende Arzneimittel |
| EP2152725A1 (de) | 2007-05-17 | 2010-02-17 | Neopro Labs, LLC | Kristalline und amorphe peptidformen |
| WO2008148161A1 (en) | 2007-06-07 | 2008-12-11 | Simons Haplomics Limited | In situ methods for gene mapping and haplotyping |
| WO2009012472A2 (en) * | 2007-07-18 | 2009-01-22 | Neopro Labs, Llc | Methods and compositions for treating conditions |
| US7662858B2 (en) * | 2008-05-23 | 2010-02-16 | Aaipharma, Inc. | Method of treating post-surgical acute pain |
| KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
| US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
| JP2013500713A (ja) | 2009-07-31 | 2013-01-10 | サントル オスピタリエ ウニヴェルシテール ヴォドア | Hcv感染患者においてc型肝炎の転帰を診断又は予測する方法 |
| US20110052679A1 (en) | 2009-08-25 | 2011-03-03 | Pharmaceutics International, Inc. | Solid naproxen concentrates and related dosage forms |
| GB0922377D0 (en) | 2009-12-22 | 2010-02-03 | Arab Gulf University The | Mutant LDL receptor |
| EP2394641A1 (de) | 2010-05-30 | 2011-12-14 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmazeutische Formulationen von Lornoxicam |
| EP2726632A1 (de) | 2011-06-30 | 2014-05-07 | Centre Hospitaller Universitaire Vaudois (CHUV) | Polymorphismen in zusammenhang mit fehlendem ansprechen auf eine hepatitis-c-behandlung oder der anfälligkeit für nicht-spontane hepatitis-c-heilung |
| US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
| ES2699238T3 (es) * | 2012-01-30 | 2019-02-08 | Baxalta GmbH | Polisacáridos sulfatados o sulfonatados no anticoagulantes |
| SG10202010157VA (en) * | 2015-02-10 | 2020-11-27 | Axsome Therapeutics Inc | Pharmaceutical compositions comprising meloxicam |
| ITUB20161016A1 (it) * | 2016-02-24 | 2017-08-24 | Emenem Srl | Composizioni farmaceutiche o cosmetiche comprendenti un polimero e un promotore di assorbimento per il rilascio controllato di principi attivi |
| US20180150597A1 (en) | 2016-11-29 | 2018-05-31 | Genomic Vision Sa | Method for optimal design of polynucleotides sequences for analysis of specific events in any genetic region of interest |
| KR102583443B1 (ko) * | 2017-05-10 | 2023-09-26 | 액섬 테라퓨틱스, 인크. | 멜록시캄을 포함하는 약학적 조성물 |
| US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
| IL324832A (en) * | 2023-06-02 | 2026-01-01 | Ioulia Tseti | Pharmaceutical composition comprising ibuprofen |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU176215B (en) * | 1978-01-27 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 |
| JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
| IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
| GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| US5206025A (en) * | 1989-05-24 | 1993-04-27 | Rhone-Poulenc Sante | Porous pharmaceutical form and its preparation |
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| IT1241088B (it) * | 1990-03-27 | 1993-12-29 | Chiesi Farma Spa | Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche |
| EP1004318A3 (de) * | 1991-06-21 | 2002-08-07 | Takeda Chemical Industries, Ltd. | Zyklodextrin-zusammensetzung |
| US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
| GB9316580D0 (en) * | 1993-08-10 | 1993-09-29 | Smithkline Beecham Plc | Pharmaceutical composition |
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
| EP0760680A1 (de) * | 1994-05-27 | 1997-03-12 | Farmarc Nederland Bv | Pharmazeutische zusammensetzungen |
-
1995
- 1995-11-08 ZA ZA959469A patent/ZA959469B/xx unknown
- 1995-11-14 DE DE69532678T patent/DE69532678D1/de not_active Expired - Lifetime
- 1995-11-14 EP EP95936694A patent/EP0792147B1/de not_active Expired - Lifetime
- 1995-11-14 CN CN95197252A patent/CN1171738A/zh active Pending
- 1995-11-14 WO PCT/GB1995/002679 patent/WO1996014839A1/en not_active Ceased
- 1995-11-14 US US08/849,059 patent/US5854226A/en not_active Expired - Lifetime
- 1995-11-14 AT AT95936694T patent/ATE261301T1/de not_active IP Right Cessation
- 1995-11-14 JP JP8515851A patent/JPH10508835A/ja active Pending
- 1995-11-14 AU AU38538/95A patent/AU694577B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US5854226A (en) | 1998-12-29 |
| EP0792147A1 (de) | 1997-09-03 |
| CN1171738A (zh) | 1998-01-28 |
| ZA959469B (en) | 1996-05-15 |
| AU694577B2 (en) | 1998-07-23 |
| JPH10508835A (ja) | 1998-09-02 |
| AU3853895A (en) | 1996-06-06 |
| DE69532678D1 (de) | 2004-04-15 |
| WO1996014839A1 (en) | 1996-05-23 |
| EP0792147B1 (de) | 2004-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69532678D1 (de) | Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende Arzneimittel | |
| DZ1884A1 (fr) | Formulations orales liquides d'alendronate. | |
| DE69521688D1 (de) | Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung | |
| AU1079701A (en) | Oral transmucosal drug dosage using solid solution | |
| ATE280572T1 (de) | Verabreichung von arzneistoffen im unteren verdauungstrakt | |
| DE69519685D1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
| ATE205705T1 (de) | Arzneimittel zum wirkstoff - targetting in den dickdarm | |
| HUP0204159A2 (hu) | Prosztaglandin-készítmények és alkalmazásuk erekciós zavarok kezelésére szolgáló gyógyszerek előállítására | |
| ATE279914T1 (de) | Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt | |
| BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
| ATE145819T1 (de) | Inhalierbare arzneimittel | |
| AU4363000A (en) | Gum pad for delivery of medication to mucosal tissues | |
| YU2494A (sh) | Farmaceutska formulacija za tretiranje zavisnosti od nikotina | |
| ATE213633T1 (de) | Lamotrigin haltiges arzneimittel | |
| CY1110184T1 (el) | Φαρμακευτικη συνθεση για μαλακες καψουλες για χορηγηση απο το στομα η οποια περιεχει βινορελβινη και μεθοδος θεραπειας | |
| AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
| CA1333773C (en) | Antitussive liquid compositions containing phenol | |
| MXPA01009297A (es) | Composiciones bioadhesivas, medicadas, topicas y metodos para su uso y preparacion. | |
| KR950031049A (ko) | 풍미된 필름 제피를 함유하는 고형의 약제학적 용량형 | |
| HK40089892A (zh) | 含有阿戈美拉汀的经粘膜治疗系统 | |
| CA2187153A1 (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
| Turner | Maalox. Antacid: see ALUMINIUM | |
| BENSERAZIDE et al. | conditions: see DEXAMETHASONE | |
| CA2388431A1 (en) | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment | |
| TH31315B (th) | รูปขนาดใช้ยาทางเภสัชกรรมสำหรับให้ทางปาก ซึ่งประกอบรวมด้วยสารยับยั้บการดึงโปรตอน และ nsaid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |